Form 4: RPID director gifts 40,000 shares to charity

Rapid Micro Biosystems director Kirk Malloy reported a non-market gift of 40,000 Class A shares, retaining 28,600 direct and 10,000 indirect shares post-transaction.

Summary

• Director Kirk Malloy made a charitable gift of 40,000 shares of Class A Common Stock on 2025-11-14 (transaction code G).
• No sale proceeds were received; the transaction price was $0, consistent with a gift.
• Post-transaction beneficial ownership stands at 28,600 shares held directly and 10,000 shares held indirectly via a family trust.
• The donated shares were transferred to a non-profit charitable organization.
• Form was signed by Attorney-in-Fact Sean M. Wirtjes on 2025-11-18.

Sentiment

Score: 5

Explanation: Neutral impact: routine charitable gift with no cash proceeds and no change to company fundamentals; insider maintains a meaningful position.

Positives

• Non-sale charitable transfer (code G) indicates no insider disposal for personal financial gain.
• Director retains 28,600 shares directly and 10,000 shares indirectly, maintaining a meaningful ownership stake.
• Timely reporting of the transaction, consistent with Section 16 requirements.

Negatives

• Insider direct beneficial ownership decreased by 40,000 shares as a result of the gift.

Future Outlook

No forward-looking statements or guidance provided.

Management Comments

• Gift of Class A Common Stock made to a non-profit charitable organization.
• 10,000 shares are held in a family trust where investment power is shared and beneficiaries include the reporting person and/or immediate family members.

Industry Context

Insider gifts are generally viewed as neutral events across life sciences and medtech; unlike open-market purchases or sales, gifts do not signal views on valuation or fundamentals and do not affect share count.

Comparison to Industry Standards

• Consistent with standard U.S. Section 16 reporting practices: non-market gifts (code G) are common and are typically interpreted as neutral for corporate outlook.
• In contrast to insider open-market purchases (often seen as positive) or large discretionary sales (potentially negative), charitable gifts are usually governance-neutral and philanthropy-driven.
• Comparable disclosures among life sciences peers (e.g., periodic Form 4 gifts by directors/executives at similar small-cap medtech/biotech companies) are treated as routine by institutional investors.

Stakeholder Impact

• No dilution or balance sheet impact; shares transferred from an insider to a charitable organization.
• Possible incremental trading activity if the receiving organization sells shares, but no such activity is indicated.

Key Dates

Keywords

Rapid Micro Biosystems, RPID, Form 4, insider transaction, beneficial ownership, charitable gift, director, Class A Common Stock, family trust, Section 16